Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth
Monday, 31 March 2025 () SYDNEY--(BUSINESS WIRE)-- #GIC--Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund. Novotech, headquartered in Singapore with a global presence across more than 30 offices, is one of the w
Monday, 31 March 2025 ()
